BioSET

BIOSURFACE ENGINEERING TECHNOLOGIES INC. is dedicated to developing proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. The company focuses on developing devices for orthobiologics applications. Its products include AMPLEX, an implantable combination device of the B2A peptide and a synthetic ceramic scaffold, used as a surgical bone graft implant for lumbar degenerative disc disease, as well as for spinal, cervical, and foot and ankle fusion surgeries. The company also develops sports medicine application products based on its F2A peptide; and peptide signaling molecules and various scaffold biomaterials for musculoskeletal applications, including trauma, fracture repair, and other soft tissue treatments.